← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:763 | 763 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-700 | 70004-700-28 | Labetalol Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:763 | 763 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-102 | 73463-102-03 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:763 | 763 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9090 | 71266-9090-1 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:763 | 763 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-25 | Lorazepam | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:763 | 763 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0408 | 71285-0408-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:763 | 763 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5595 | 26436-5595-3 | Methionine; Inositol; Choline Chloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:763 | 763 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5354 | 26436-5354-1 | Methylene Blue | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:764 | 764 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3006 | 79559-3006-1 | S-E006 | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:764 | 764 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:764 | 764 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2011 | 71286-2011-1 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:764 | 764 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-21 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:764 | 764 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:764 | 764 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0431 | 72196-0431-1 | Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:764 | 764 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:764 | 764 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine; Prilocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:764 | 764 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-024 | 71449-024-11 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:764 | 764 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-503 | 65302-503-04 | Labetalol Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:764 | 764 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-100 | 73463-100-01 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:764 | 764 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-3 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:764 | 764 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:764 | 764 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0406 | 72196-0406-1 | Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:764 | 764 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6420 | 72682-6420-1 | Methionine; Inositol; Choline Chloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:764 | 764 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:765 | 765 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-811 | 71170-811-02 | Semaglutide 2.25 mg | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:765 | 765 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:765 | 765 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:765 | 765 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:765 | 765 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:765 | 765 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1621 | 5446-1621-01 | Hyaluronidase-1 Bovine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:765 | 765 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:765 | 765 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3100 | 72627-3100-1 | Lidocaine; Benzocaine; Tetracaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:765 | 765 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-043 | 71506-043-01 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:765 | 765 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0423 | 72196-0423-1 | Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:765 | 765 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:765 | 765 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:765 | 765 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0416 | 72196-0416-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:765 | 765 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-5974 | 72682-5974-1 | Lysine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:765 | 765 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5594 | 26436-5594-3 | Methionine; Inositol; Choline Chloride; Cyanocobalamin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:765 | 765 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:766 | 766 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6058 | 71285-6058-1 | Phenylephrine 10mg added to NS | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:766 | 766 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:766 | 766 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:766 | 766 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:766 | 766 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:766 | 766 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-551 | 69374-551-01 | Hydralazine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:766 | 766 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:766 | 766 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3101 | 72627-3101-1 | Lidocaine; Benzocaine; Tetracaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:766 | 766 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0000 | 81483-0000-0 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:766 | 766 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0423 | 71285-0423-1 | Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Threonine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:766 | 766 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:766 | 766 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9091 | 71266-9091-1 | Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:766 | 766 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0422 | 71285-0422-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:766 | 766 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2417 | 72627-2417-1 | Lysine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:766 | 766 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5596 | 26436-5596-1 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:766 | 766 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-5 | Methylprednisolone Acetate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:767 | 767 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-140 | 73702-140-71 | Indomethacin | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:767 | 767 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:767 | 767 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:767 | 767 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-9021 | 26436-9021-4 | Hydromorphone Hydrochloride; Bupivacaine Hydrochloride Related Compound A | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:767 | 767 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:767 | 767 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:767 | 767 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:767 | 767 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3150 | 72627-3150-9 | Lidocaine; Prilocaine; Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:767 | 767 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0001 | 81483-0001-1 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:767 | 767 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-111 | 73702-111-15 | Lidocaine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:767 | 767 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:767 | 767 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5480 | 26436-5480-1 | Lidocaine Hydrochloride Anhydrous | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:767 | 767 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0408 | 71285-0408-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:767 | 767 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5080 | 26436-5080-3 | Lysine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:767 | 767 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5596 | 26436-5596-3 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:767 | 767 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-3 | Methylprednisolone Acetate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:768 | 768 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5473 | 26436-5473-1 | BLT Topical Gel | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:768 | 768 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-049 | 70713-049-01 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:768 | 768 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:768 | 768 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-9020 | 26436-9020-2 | Hydromorphone Hydrochloride; Bupivacaine Hydrochloride Related Compound A | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:768 | 768 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:768 | 768 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:768 | 768 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0600 | 60652-0600-2 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:768 | 768 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3220 | 72627-3220-9 | Lidocaine; Prilocaine; Phenylephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:768 | 768 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0002 | 81483-0002-0 | Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:768 | 768 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:768 | 768 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-27 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:768 | 768 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-164 | 63037-164-25 | Lidocaine Hydrochloride Anhydrous | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:768 | 768 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0406 | 72196-0406-1 | Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:768 | 768 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine Hydrochloride; Arginine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:768 | 768 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-310 | 70092-310-46 | Methohexital Sodium | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:768 | 768 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-6 | Midazolam | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:769 | 769 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2566 | 72934-2566-2 | Aluris | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:769 | 769 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-144 | 70713-144-01 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:769 | 769 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0600 | 60652-0600-2 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:769 | 769 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxocobalamin | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:769 | 769 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:769 | 769 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-983 | 69374-983-30 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:769 | 769 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-1 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:769 | 769 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-2552 | 73271-2552-1 | Lidocaine; Prilocaine; Tetracaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:769 | 769 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:769 | 769 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:769 | 769 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-06 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:769 | 769 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-162 | 63037-162-25 | Lidocaine Hydrochloride Anhydrous | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:769 | 769 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5080 | 26436-5080-3 | Lysine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:769 | 769 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-988 | 69374-988-10 | Lysine Hydrochloride; Arginine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:769 | 769 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methotrexate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:769 | 769 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-2 | Midazolam | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:770 | 770 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2431 | 72627-2431-1 | Magnesium Chloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:770 | 770 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-009 | 70713-009-01 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:770 | 770 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:770 | 770 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxocobalamin | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:770 | 770 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:770 | 770 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-983 | 69374-983-50 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:770 | 770 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-2 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:770 | 770 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-3552 | 73271-3552-1 | Lidocaine; Prilocaine; Tetracaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:770 | 770 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:770 | 770 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:770 | 770 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-03 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:770 | 770 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-486 | 68985-486-93 | Lidocaine Hydrochloride Anhydrous; Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:770 | 770 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-5974 | 72682-5974-1 | Lysine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:770 | 770 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6010 | 72682-6010-1 | Lysine Hydrochloride; Arginine Hydrochloride; Proline; Glutamine | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:770 | 770 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:770 | 770 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-401 | 73702-401-02 | Midazolam | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:771 | 771 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-2 | Midazolam | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:771 | 771 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-050 | 70713-050-01 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:771 | 771 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:771 | 771 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0339 | 71283-0339-3 | Hydroxocobalamin | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:771 | 771 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:771 | 771 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0600 | 60652-0600-2 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:771 | 771 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2011 | 71286-2011-1 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:771 | 771 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1552 | 73271-1552-1 | Lidocaine; Prilocaine; Tetracaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:771 | 771 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8091 | 71285-8091-1 | Lidocaine Hydrochloride Anhydrous | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:771 | 771 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-098 | 73198-098-30 | Lidocaine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:771 | 771 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-120 | 70092-120-43 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:771 | 771 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6290 | 71266-6290-1 | Lidocaine Hydrochloride; Epinephrine Bitartrate; Tetracaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:771 | 771 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine Hydrochloride; Arginine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:771 | 771 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-9415 | 72682-9415-1 | Lysine Hydrochloride; Arginine Hydrochloride; Proline; Glutamine | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:771 | 771 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:771 | 771 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-04 | Midazolam | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:772 | 772 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-004 | 68985-004-94 | PHENYLEPHRINE 40MG | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:772 | 772 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-147 | 70713-147-01 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:772 | 772 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:772 | 772 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxocobalamin | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:772 | 772 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-01 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:772 | 772 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-01 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:772 | 772 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2012 | 71286-2012-1 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:772 | 772 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-8114 | 73271-8114-1 | Lidocaine; Prilocaine; Tetracaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:772 | 772 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8088 | 71285-8088-1 | Lidocaine Hydrochloride Anhydrous | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:772 | 772 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-097 | 73198-097-30 | Lidocaine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:772 | 772 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:772 | 772 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:772 | 772 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-988 | 69374-988-10 | Lysine Hydrochloride; Arginine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:772 | 772 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:772 | 772 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:772 | 772 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-05 | Midazolam | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:773 | 773 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-244 | 71170-244-25 | Vancomycin 750mg added to 250mL of 0.9% Sodium Chloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:773 | 773 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-056 | 70713-056-01 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:773 | 773 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:773 | 773 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxychloroquine Sulfate | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:773 | 773 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-03 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:773 | 773 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-03 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:773 | 773 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:773 | 773 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-4552 | 73271-4552-1 | Lidocaine; Prilocaine; Tetracaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:773 | 773 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8089 | 71285-8089-1 | Lidocaine Hydrochloride Anhydrous | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:773 | 773 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:773 | 773 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:773 | 773 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:773 | 773 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-9415 | 72682-9415-1 | Lysine Hydrochloride; Arginine Hydrochloride; Proline; Glutamine | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:773 | 773 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride; Zinc Sulfate Heptahydrate; Copper Gluconate; Manganese Sulfate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:773 | 773 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5015 | 26436-5015-3 | Methylcobalamin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:773 | 773 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0027 | 81483-0027-1 | Midazolam | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:774 | 774 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-740 | 69194-740-01 | 740 LIDOCAINE HCl 4% BOTTLE | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:774 | 774 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-053 | 70713-053-01 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:774 | 774 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:774 | 774 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3256 | 62295-3256-1 | Hydroxychloroquine Sulfate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:774 | 774 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-04 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:774 | 774 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-05 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:774 | 774 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:774 | 774 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-5114 | 73271-5114-1 | Lidocaine; Prilocaine; Tetracaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:774 | 774 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-486 | 68985-486-92 | Lidocaine Hydrochloride Anhydrous; Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:774 | 774 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:774 | 774 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-050 | 71506-050-56 | Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:774 | 774 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:774 | 774 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6010 | 72682-6010-1 | Lysine Hydrochloride; Arginine Hydrochloride; Proline; Glutamine | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:774 | 774 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0202 | 71285-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:774 | 774 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5354 | 26436-5354-1 | Methylene Blue | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:774 | 774 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-418 | 70092-418-36 | Midazolam Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:775 | 775 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-982 | 69374-982-55 | Ketamine Hydrochloride 30 mg/3 mL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:775 | 775 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-145 | 70713-145-01 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:775 | 775 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:775 | 775 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0532 | 71283-0532-5 | Hydroxyprogesterone Caproate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:775 | 775 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-05 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:775 | 775 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-529 | 69374-529-30 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:775 | 775 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:775 | 775 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-6114 | 73271-6114-1 | Lidocaine; Prilocaine; Tetracaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:775 | 775 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-486 | 68985-486-93 | Lidocaine Hydrochloride Anhydrous; Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:775 | 775 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:775 | 775 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1213 | 73271-1213-1 | Ketoconazole | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:775 | 775 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-090 | 71449-090-42 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:775 | 775 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:775 | 775 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0202 | 72196-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:775 | 775 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-3 | Methylprednisolone Acetate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:775 | 775 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:776 | 776 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-521 | 70092-521-74 | Morphine PF 1 mg/ml 50 ml NS CADD FSFF | 2024-2 | valid | 0 | 2026-09-18 |